Aptevo Therapeutics Inc. (APVO) Operating margin 2016–2023
Aptevo Therapeutics Inc. (APVO) operating margin by fiscal year — reported operating income divided by reported revenue.
-927.4%FY2023 · since FY2016: -413.0% → -927.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -927.4% | -694.4 pp |
| FY2022 | -233.0% | +263.6 pp |
| FY2021 | -496.6% | -411.8 pp |
| FY2020 | -84.8% | +92.8 pp |
| FY2019 | -177.6% | +174.9 pp |
| FY2018 | -352.5% | +187.8 pp |
| FY2017 | -540.3% | -127.3 pp |
| FY2016 | -413.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice